Class II — Magnolia Medical Technologies, Inc.
| Recalling firm | Magnolia Medical Technologies |
|---|---|
| Registered facility | MAGNOLIA MEDICAL TECHNOLOGIES, INC. (the firm's only registered facility) |
| Classification | Class II |
| Status | Terminated |
| Reason | Due to an uptick of complaints associated with premature needle retraction of blood collection system. |
| Product | The Steripath Gen2 Blood Collection System Model Number/Description 2700-21-EN / Steripath Gen2 Blood Collection System - 21G, Wide Neck 2700-23-EN / Steripath Gen2 Blood Collection System - 23G, Wide Neck 27BD-21-EN / Steripath Gen2 Blood Collection System - 21G, Long Neck 27BD-23-EN / Steripath Gen2 Blood Collection System - 23G, Long Neck |
| Quantity | 137,200 devices |
| Distribution | U.S. Nationwide distribution in the states of MD, WV, DE, VA, DC, IN, MI, MA, SC, NY, IL, TX, AL, OK, GA, NE, FL, MO, CA, CO, NM, AR, WY, KS, PA, WA, MT, and AZ. |
| Initiated | 2021-11-02 |
| Classified | 2021-12-01 |
| Terminated | 2023-05-08 |
| Recall number | Z-0318-2022 |
| Initiation | Voluntary: Firm initiated |
Source: U.S. FDA via openFDA (opens in a new tab) (device registration & enforcement). Data as of 2026-10-06. Verify this recall record at FDA → (opens in a new tab)
Cite this record
RegWarden. “Class II recall — Magnolia Medical Technologies, Inc. (Z-0318-2022).” Compiled from U.S. FDA public records (openFDA; FDA Data Dashboard). Data as of 2026-10-06. https://regwarden.com/recall/88919/
Alerts for Magnolia Medical Technologies
Watchlist alerts will email you when FDA publishes a new recall, inspection classification, or warning letter for a facility you follow. They aren't open to the public yet — leave your email and we'll tell you when they are.
Want a one-page facility brief?
A single-page summary of this facility's registration and recall history for diligence. Not selling it yet — register interest and we'll follow up.